Abstract Introduction Alzheimer’s disease (AD) staging has evolved rapidly with the introduction of biological definitions, expanded biomarker modalities and updated diagnostic frameworks. Multiple staging criteria are now used across research and clinical settings yet their real-world application remains unclear. Diff...
Nazmul Islam, F. Foroutan, Theodore M. Johnson et al.· BMJ Open· 0 citations
Abstract BACKGROUND This systematic review and meta‐analysis aimed to assess the accuracy of brief (i.e., ≤15 minutes), freely available cognitive tests for the early detection of cognitive impairment (including mild cognitive impairment and dementia) in adults 55 years and older in primary and specialty care. METHODS...
Jennifer Loveless, L. Pilcher, Corey J. Bolton et al.· Alzheimer's & Dementia· 0 citations
Key takeaways from the Fall 2025 AARR meeting are presented, which brought together academic, clinical, and industry leaders to discuss and explore the current advances in the heterogeneity and co‐pathologies of AD and their implications for diagnosis, clinical trial design, and precision treatment strategies.
M. Tansey, S. Bozeat, Peter Ackerman et al.· Alzheimer's & Dementia· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.